文献速递白血病造血干细胞移植与细胞治疗

复合CAR-T细胞靶向CD123与CD33双靶点治疗急性髓系白血病的研究

Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia.
PubMed 文献 · Leukemia · 2018-02-25

急性髓系白血病(AML)细胞异质性可导致单靶点CAR-T治疗失败与复发,CD123阳性的白血病干细胞(LSC)在疾病进展和复发中起重要作用。本研究构建了同时靶向CD123和CD33的复合CAR(cCAR)T细胞,体外显示对两种靶抗原群体均有强效定向细胞毒作用,并在四种白血病小鼠模型中观察到cCAR治疗后体内生存优势;同时设计了阿仑单抗安全开关可在体内快速终止cCAR治疗。

要点

  • 复合CAR-T细胞同时靶向CD123和CD33,体外对两种靶抗原群体均具强效定向细胞毒作用。
  • 在四种白血病小鼠模型中,cCAR治疗后的体内生存优于对照。
  • 设计了阿仑单抗安全开关,可在体内快速终止cCAR治疗。

核心结论

  • 同时靶向AML细胞上的CD123和CD33可能是清除AML bulk疾病和LSC的有效策略,并可能预防因抗原逃逸或LSC持续存在导致的复发。

研究设计与样本

  • 研究构建了同时靶向CD123和CD33的复合CAR(cCAR)T细胞,并在体外及四种白血病小鼠模型中评估其抗肿瘤活性。

主要发现

  • cCAR T细胞对每种靶抗原群体均具有一致、强效且定向的细胞毒作用。
  • 在四种白血病小鼠模型中,cCAR治疗后的体内生存优于对照。
  • 设计的阿仑单抗安全开关可在体内快速终止cCAR治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute myeloid leukemia (AML) bears heterogeneous cells that can consequently offset killing by single-CAR-based therapy, which results in disease relapse. Leukemic stem cells (LSCs) associated with CD123 expression comprise a rare population that also plays an important role in disease progression and relapse. Here, we report on the robust anti-tumor activity of a compound CAR (cCAR) T-cell possessing discrete scFv domains targeting two different AML antigens, CD123, and CD33, simultaneously. We determined that the resulting cCAR T-cells possessed consistent, potent, and directed cytotoxicity against each target antigen population. Using four leukemia mouse models, we found superior in vivo survival after cCAR treatment. We also designed an alemtuzumab safety-switch that allowed for rapid cCAR therapy termination in vivo. These findings indicate that targeting both CD123 and CD33 on AML cells may be an effective strategy for eliminating both AML bulk disease and LSCs, and potentially prevent relapse due to antigen escape or LSC persistence.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Petrov JC, Wada M, Pinz KG, et al. Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia. Leukemia. 2018. PMID: 29515236. doi:10.1038/s41375-018-0075-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。